首页|Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

扫码查看
? 2021 Elsevier B.V.Myeloid-derived suppressor cells (MDSCs) play a major role in cancer progression. In this study, we investigated the mechanisms by which complement C5a increases the capacity of polymorphonuclear MDSCs (PMN-MDSCs) to promote tumor growth and metastatic spread. Stimulation of PMN-MDSCs with C5a favored the invasion of cancer cells via a process dependent on the formation of neutrophil extracellular traps (NETs). NETosis was dependent on the production of high mobility group box 1 (HMGB1) by cancer cells. Moreover, C5a induced the surface expression of the HMGB1 receptors TLR4 and RAGE in PMN-MDSCs. In a mouse lung metastasis model, inhibition of C5a, C5a receptor-1 (C5aR1) or NETosis reduced the number of circulating-tumor cells (CTCs) and the metastatic burden. In support of the translational relevance of these findings, C5a was able to stimulate migration and NETosis in PMN-MDSCs obtained from lung cancer patients. Furthermore, myeloperoxidase (MPO)-DNA complexes, as markers of NETosis, were elevated in lung cancer patients and significantly correlated with C5a levels. In conclusion, C5a induces the formation of NETs from PMN-MDSCs in the presence of cancer cells, which may facilitate cancer cell dissemination and metastasis.

C5a/C5aR1HMGB1Lung metastasisMyeloid-derived suppressor cellsNETosis

Lecanda F.、Ajona D.、Pio R.、Ortiz-Espinosa S.、Morales X.、Senent Y.、Alignani D.、Tavira B.、Macaya I.、Ruiz B.、Moreno H.、Remirez A.、Sainz C.、Rodriguez-Pena A.、Oyarbide A.、Ariz M.、Andueza M.P.、Valencia K.、Teijeira A.、Hoehlig K.、Vater A.、Rolfe B.、Woodruff T.M.、Lopez-Picazo J.M.、Vicent S.、Kochan G.、Escors D.、Gil-Bazo I.、Perez-Gracia J.L.、Montuenga L.M.、Lambris J.D.、Ortiz de Solorzano C.

展开 >

Program in Solid Tumors Cima-University of Navarra

Navarra's Health Research Institute (IDISNA)

Department of Oncology Clínica Universidad de Navarra

Program in Immunology and Immunotherapy Cima-University of Navarra

Aptarion Biotech

School of Biomedical Sciences Faculty of Medicine University of Queensland

Department of Pathology and Laboratory Medicine University of Pennsylvania

展开 >

2022

Cancer letters

Cancer letters

SCI
ISSN:0304-3835
年,卷(期):2022.529
  • 16
  • 64